BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7989717)

  • 1. A clinicopathologic study of chronic non-A, non-B (type C) hepatitis in Taiwan: comparison between posttransfusion and sporadic patients.
    Kao JH; Tsai SL; Chen PJ; Yang PM; Sheu JC; Lai MY; Hsu HC; Sung JL; Wang TH; Chen DS
    J Hepatol; 1994 Aug; 21(2):244-9. PubMed ID: 7989717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis.
    Di Bisceglie AM; Goodman ZD; Ishak KG; Hoofnagle JH; Melpolder JJ; Alter HJ
    Hepatology; 1991 Dec; 14(6):969-74. PubMed ID: 1959884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus in a prospective study of posttransfusion non-A, non-B hepatitis in Taiwan.
    Wang JT; Wang TH; Lin JT; Sheu JC; Sung JL; Chen DS
    J Med Virol; 1990 Oct; 32(2):83-6. PubMed ID: 2177776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of viremia in patients with type-C chronic hepatitis during long-term follow-up.
    Yousuf M; Nakano Y; Tanaka E; Sodeyama T; Kiyosawa K
    Scand J Gastroenterol; 1992 Sep; 27(9):812-6. PubMed ID: 1384112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of a numerical scoring system for assessment of histological outcome in patients with chronic posttransfusion non-A, non-B hepatitis with or without antibodies to hepatitis C.
    Mattsson L; Weiland O; Glaumann H
    Liver; 1990 Oct; 10(5):257-63. PubMed ID: 2175005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological outcome in interferon alpha-2b treated patients with chronic posttransfusion non-A, non-B hepatitis.
    Schvarcz R; Glaumann H; Weiland O; Norkrans G; Wejstål R; Frydén A
    Liver; 1991 Feb; 11(1):30-8. PubMed ID: 1646369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of posttransfusion hepatitis in Taiwan.
    Wang TH; Wang JT; Lin JT; Sheu JC; Sung JL; Chen DS
    J Hepatol; 1991 Jul; 13(1):38-43. PubMed ID: 1655869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of chronic hepatitis non-A, non-B--with special reference to hepatitis C.
    Wejstål R; Hermodsson S; Norkrans G
    Liver; 1991 Jun; 11(3):143-8. PubMed ID: 1715964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to hepatitis C virus in prospectively followed patients with posttransfusion hepatitis.
    Lee SD; Hwang SJ; Lu RH; Lai KH; Tsai YT; Lo KJ
    J Infect Dis; 1991 Jun; 163(6):1354-7. PubMed ID: 1645386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotyping of hepatitis C virus: coinfection by multiple genotypes detected in children with chronic posttransfusion hepatitis C.
    Matsubara T; Sumazaki R; Shin K; Nagai Y; Takita H
    J Pediatr Gastroenterol Nutr; 1996 Jan; 22(1):79-84. PubMed ID: 8788292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis.
    Tremolada F; Casarin C; Alberti A; Drago C; Tagger A; Ribero ML; Realdi G
    J Hepatol; 1992 Nov; 16(3):273-81. PubMed ID: 1487603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic non-A, non-B hepatitis developed after transfusions, illicit self-injections or sporadically. Outcome during long-term follow-up--a comparison.
    Mattsson L; Weiland O; Glaumann H
    Liver; 1989 Apr; 9(2):120-7. PubMed ID: 2496281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.
    Kiyosawa K; Sodeyama T; Tanaka E; Gibo Y; Yoshizawa K; Nakano Y; Furuta S; Akahane Y; Nishioka K; Purcell RH
    Hepatology; 1990 Oct; 12(4 Pt 1):671-5. PubMed ID: 2170265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody to hepatitis C virus in post-transfusion hepatitis.
    Tremolada F; Casarin C; Tagger A; Ribero ML; Realdi G; Alberti A; Ruol A
    Ann Intern Med; 1991 Feb; 114(4):277-81. PubMed ID: 1846277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis C.
    Sherlock DS
    Dis Mon; 1994 Mar; 40(3):117-96. PubMed ID: 7513276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal role of hepatitis B virus in posttransfusion non-A, non-B hepatitis in Taiwan: a study by polymerase chain reaction.
    Wang JT; Sheu JC; Lin JT; Shih LN; Chen DS; Wang TH
    J Formos Med Assoc; 1991 May; 90(5):471-5. PubMed ID: 1680985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologic activity of the liver in children with transfusion-associated chronic hepatitis C.
    Inui A; Fujisawa T; Miyagawa Y; Sekine I; Hanada R; Yamamoto K; Shiihara H; Inui M
    J Hepatol; 1994 Nov; 21(5):748-53. PubMed ID: 7890889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.